{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:50:41Z","timestamp":1791535841295,"version":"4.3.4"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Routine targeted genomic profiling in non-small cell lung cancer (NSCLC) is primarily used to identify actionable alterations but may provide more information for clinical decision making. In this study routine genomic profiling data were used to examine the mutational landscape of lung cancer and its relationship to patient characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We analyzed Archer VariantPlex 67-gene sequencing data from 528 patients diagnosed with lung cancer in the North Swedish Health Care Region between 2011 and 2021 and linked the genomic results to registry-derived clinical and demographic data. Mutation frequencies, positional architectures, subgroup enrichments, and survival associations were compared within the regional cohort and against an external reference cohort assembled from cBioPortal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After quality filtering, 1,415 somatic variants across 60 genes were identified, with a mean of 2.68 mutations per tumor, indicating substantial heterogeneity in mutational profiles. TP53 and KRAS formed a conserved mutational backbone across cohorts, whereas EGFR was less frequent and MET, APC, ATM, and CDKN2A were enriched in North Sweden relative to the external reference cohort. Major hotspot architectures were broadly preserved, although MET showed the clearest positional divergence. Mutation patterns varied by age, sex, smoking status, and disease stage. EGFR defined the most coherent clinical subtype, being enriched in females, never-smokers, younger patients, and earlier-stage disease, whereas KRAS, STK11, and TP53 were associated with smoking. EGFR was the strongest favorable prognostic marker, but stage strongly influenced the interpretation of many survival differences, indicating that gene-level prognostic signals are closely shaped by clinical context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Routine genomic profiling in NSCLC provides clinically relevant information beyond actionable driver detection when interpreted together with stage, smoking history, age, sex, and regional molecular context. These findings support a more context-aware interpretation of routine molecular diagnostics in thoracic oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1882423","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:24:31Z","timestamp":1790051071000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Real world genomic profiling in non-small cell lung cancer reveals regional variations with clinical implications"],"prefix":"10.3389","volume":"16","author":[{"given":"Nicholas","family":"Karlowatz","sequence":"first","affiliation":[{"name":"Department of Diagnostics and Intervention, Oncology, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"K\u00f6hn","sequence":"additional","affiliation":[{"name":"Department of Medical Biosciences, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Patthey","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Intervention, Oncology, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Intervention, Oncology, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael B","family":"Johansson","sequence":"additional","affiliation":[{"name":"Department of Diagnostics and Intervention, Oncology, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","unstructured":"Cancer I Siffror 2023\n          \n          \n          Stockholm\n          Socialstyrelsen\n          National Cancer Register\n          \n          2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa1715907","article-title":"Higher lung cancer incidence in young women than young men in the United States","volume":"378","author":"Jemal","year":"2018","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s41588-021-00920-0","article-title":"Genomic and evolutionary classification of lung cancer in never smokers.","volume":"53","author":"Zhang","year":"2021","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckad219","article-title":"Changing smoking habits and the occurrence of lung cancer","volume":"34","author":"J\u00e4rvholm","year":"2024","journal-title":"Eur J Public Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer","volume":"75","author":"Campisi","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2021.100194","article-title":"The genomics of young lung cancer: comprehensive tissue genomic analysis in patients under 40 with lung cancer","volume":"2","author":"Gitlitz","year":"2021","journal-title":"JTO Clin Res Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-5030","article-title":"Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms","volume":"14","author":"Bell","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.12.61","article-title":"Influence of estrogen in non-small cell lung cancer and its clinical implications","volume":"10","author":"Rodriguez-Lara","year":"2018","journal-title":"J Thorac Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230796","article-title":"Transcriptome analysis reveals gender-specific differences in overall metabolic response of male and female patients in lung adenocarcinoma","volume":"15","author":"Li","year":"2020","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-3265","article-title":"Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers","volume":"18","author":"Dogan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.06.021","article-title":"Dietary factors and lung cancer risk: a comprehensive systematic review of meta-analyses","volume":"51","author":"Cao","year":"2015","journal-title":"Eur J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05874-3","article-title":"Lung adenocarcinoma promotion by air pollutants","volume":"616","author":"Hill","year":"2023","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer progress and priorities: lung cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s41588-021-00920-0","article-title":"Genomic and evolutionary classification of lung cancer in never smokers","volume":"53","author":"Zhang","year":"2021","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.ccell.2023.03.018","article-title":"Genomic mapping of metastatic organotropism in lung adenocarcinoma","volume":"41","author":"Lengel","year":"2023","journal-title":"Cancer Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.jtho.2020.08.005","article-title":"The underlying tumor genomics of predominant histologic subtypes in lung adenocarcinoma","volume":"15","author":"Caso","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3564","article-title":"Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas","volume":"48","author":"Campbell","year":"2016","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41588-019-0569-6","article-title":"Genomic landscape of lung adenocarcinoma in East Asians","volume":"52","author":"Chen","year":"2020","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2013.03.002","article-title":"Lessons from the cancer genome","volume":"153","author":"Garraway","year":"2013","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature12947","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00026-1","article-title":"Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6","volume":"16","author":"Yang","year":"2015","journal-title":"Lancet Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3854","article-title":"Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M","volume":"21","author":"Thress","year":"2015","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cllc.2023.05.002","article-title":"KRAS G12C mutant non-small cell lung cancer linked to female sex and high risk of CNS metastasis: population-based demographics and survival data from the National Swedish Lung Cancer Registry","volume":"24","author":"Isaksson","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71250","article-title":"Comprehensive genomic profiling in advanced non-small cell lung cancer: a real-world cohort study in Finland","volume":"14","author":"Hormalainen","year":"2025","journal-title":"Cancer Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004407","article-title":"Tepotinib in non-small-cell lung cancer with MET exon 14 skipping mutations","volume":"383","author":"Paik","year":"2020","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0285","article-title":"Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors","volume":"5","author":"Frampton","year":"2015","journal-title":"Cancer Discov"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.03485","article-title":"Adenomatous polyposis coli (APC): a multi-functional tumour suppressor gene","volume":"120","author":"Aoki","year":"2007","journal-title":"J Cell Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3413","article-title":"Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer","volume":"29","author":"Ricciuti","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","article-title":"Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy","volume":"19","author":"Skoulidis","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2023","article-title":"Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer","volume":"8","author":"Bhateja","year":"2019","journal-title":"Cancer Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov"},{"key":"B37","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jtho.2021.10.013","article-title":"Diminished efficacy of programmed death-(ligand)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is affected by KRAS mutation status","volume":"17","author":"Ricciuti","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/12687","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.eururo.2022.09.030","article-title":"FGFR3 mutational activation can induce luminal-like papillary bladder tumor formation and favors a male sex bias","volume":"83","author":"Shi","year":"2023","journal-title":"Eur Urol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semcancer.2014.01.001","article-title":"Retinoblastoma protein: a master regulator of cell cycle, differentiation, and apoptosis","volume":"26","author":"Knudsen","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.02.023","article-title":"Driver mutation characteristics of PIK3CA in advanced non-small cell lung cancer","volume":"178","author":"Daher","year":"2023","journal-title":"Lung Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrc3037","article-title":"PTEN loss in the continuum of common cancers, rare syndromes and mouse models","volume":"11","author":"Hollander","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2017.06.004","article-title":"Cell cycle control by PTEN","volume":"429","author":"Brandmaier","year":"2017","journal-title":"J Mol Biol"}],"updated-by":[{"DOI":"10.3389\/fonc.2026.2013767","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1882423\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:16:38Z","timestamp":1791533798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1882423\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":43,"alternative-id":["10.3389\/fonc.2026.1882423"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1882423","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1882423"}}